Inari Medical, Inc. (NARI) Misses Q4 EPS by 9c, Beats on Revenue

Inari Medical, Inc. (NASDAQ: NARI) reported Q4 EPS of ($0.08), $0.09 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $132.1 million versus the consensus estimate of $131.76 million.

For earnings history and earnings-related data on Inari Medical, Inc. (NARI) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Bernstein SocGen on Oracle (ORCL): 'Next catalyst is FAM'
• Oracle’s Ellison cancels plan to sell up to 50 mln shares